popular wires

IMDEX Limited (ASX:IMD) recently delivered a solid first quarter update to the market after delivering a record revenue in the period to March 2020. In the latest...

This is yesterday's Strategy podcast from Marcus at Marcus Today - this was our initial reaction to the Vaccine news - the podcast, which we do daily for Members,...

Local market had a strong day despite patchy US lead with DOW up 0.9% and NASDAQ down 1.4%. The local market was jammed up by global investors chasing the currency all...

The dramatic drop in cash and term deposit rates this year has been challenging for investors, particularly retirees who depend on regular, reliable income streams....

This week – less than a year after the COVID-19 coronavirus first emerged – biopharma companies Pfizer and BioNTech announced that their novel vaccine candidate for...

The anticipated blue wave carrying Joe Biden to the US presidency may have been overstated but history suggests a divided government is no bad thing for markets. And...

China A-shares have done well this year, rising by double-digit percentage points, and outperforming Asian and developed counterparts. Additionally, the wealth...

In this video, Talaria CIO Chad Padowitz talks through some of the impacts of a Biden win on global markets, including the recent Pfizer announcement of a potential...

Centuria Healthcare has settled approximately $115m worth of day and short-stay hospitals for its recently launched open-ended unlisted Centuria Healthcare Property...

In a recent two-part series, I showed that successful investment isn’t a matter of raw brainpower; instead, it’s primarily the result of refined character – and...

Investing in biotech is often seen as binary: you either win big or lose everything. The success of CSL has been well chronicled, however, is it possible to...

Limit your forecast period to between three and five years and don’t obsess about buying the highest returning stock, says Richard Ivers, portfolio manager of the...

The ASX200 disappointed many investors on Tuesday only rallying 42-points after opening up nearer 140-points. The issue was we witnessed the most aggressive sector...

There's never been more interest in companies and funds that are focused on investing in growth, innovation, sustainability and impact. Investing in 'the future'...

Local market had a strong lead from the US but the momentum only delivered a solid positive start that faded through the day as the election uncertainties and vaccine...

There’s a ‘something for nothing’ element with mining royalties: the holder takes none or little of the risk in extracting the commodity while enjoying a virtually...

Well, that wasn’t supposed to happen. Not after all the hand-wringing, ripping up the models and changed polling techniques that happened after the 2016 election. As...

In the first half of 2020, investors were piling money into hydrogen-linked stocks. During the second quarter, the stock price of hydrogen-powered car company...

In massive news overnight, Pfizer and its German partner BioNTech have reported that its novel, two dose "mRNA" vaccine has been more than 90% effective thus far in...

With Alphinity celebrating its 10th anniversary we have explored what has happened in the healthcare sector in the decade since Alphinity was first established. Over...